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The oral antidiabetic sulfonylurea PH]glibenclamide specifically binds to plasma membranes from a rat /?-cell tumor indi- 
cating a receptor for sulfonylureas in these membranes. Irradiation of PH]glibenclamide at 254 or 300 nm in the presence 
of albumin resulted in covalent labeling of the albumin molecule. Direct photoaffinity labeling of p-cell membranes with 
PH]glibenclamide resulted in the covalent modification of two membrane polypeptides with apparent molecular masses 
140 and 33 kDa. The extent of labeling of the 140 kDa polypeptide was specifically decreased by sulfonylureas. This 
suggests that a membrane polypeptide of 140 kDa is a component of the sulfonylurea receptor in the @ell membrane. 
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1. INTRODUCTION 
Sulfonylureas are widely used in the treatment 
of non-insulin-dependent diabetes mellitus. The 
molecular mechanisms of insulin release from 
islets of Langerhans by the action of sulfonylureas 
are still not yet fully understood [1,2]. Specific 
binding of sulfonylureas to receptors of the &cell 
membrane has been shown [3-61. It has been sug- 
gested that tolbutamide decreases the K+ 
permeability of &cell membranes [7,8]. By patch- 
clamp experiments it has been shown that the 
hypoglycemic sulfonylureas inhibit an ATP- 
sensitive K+ channel [9- 151. From these data it has 
been suggested that the sulfonylurea receptor may 
be part of an ATP-sensitive K+ channel [9,10]. 
However, protein components of the sulfonylurea 
receptor of &cell membranes have not yet been 
identified. Since the technique of photoaffinity 
labeling has been successfully used for the iden- 
tification of membrane receptors [ 16-181, in the 
present study we have used [3H]glibenclamide as a 
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photoaffinity probe for the sulfonylurea receptor 
of the P-cell membrane derived from a rat tumor. 
2. MATERIALS AND METHODS 
2.1. Materials 
[‘H]Glibenclamide (spec. act. 31 Ci/mmol) was synthesized 
as in [3]. Glibenclamide and tolbutamide were from Hoechst 
Aktiengesellschaft (Frankfurt). Molecular mass marker pro- 
teins for electrophoresis were obtained from Sigma (Muncher& 
whereas the chemicals for electrophoresis were from Serva 
(Heidelberg). Quickszint@ 501 and Bioluteo were obtained from 
Zinsser Analytic (Frankfurt). 
2.2. Preparation of &cell membranes 
,&Cell membranes from the rat &cell tumor grown in rats of 
the strain NEDH (New England Deaconess Hospital, obtained 
from S. Warren [19]) were prepared as described [3] and stored 
at -70°C. 
2.3. Photoaffinity labeling 
For photoaffinity labeling of albumin with 
[‘Hlglibenclamide, solutions of human serum albumin 
(1 mg/ml) in 100 mM sodium phosphate buffer (pH 7.4) were 
incubated in the dark at 20°C with 0.25 /tM [3H]glibenclamide 
for 60 min. Irradiation was performed in a Rayonet RPR 100 
photochemical reactor (Southern Ultraviolet Co., Hamden, 
CT), equipped with 16 RPR 2530, 3000 or 3500 A lamps at a 
distance of 10 cm from the lamps. After definite times aliquots 
were removed, adjusted to 200~1 with water and protein 
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precipitated as in (201. For photoaffinity labeling of &cell mem- 
branes, membranes were thawed at 30°C and resuspended in 
100 mM sodium phosphate buffer (pH 7.4). 600/g of &cell 
membranes were incubated in a total volume of 200~1 with 
40-60 nM (0.3-0.4 ,&i) [“Hlglibenclamide at 20°C in the dark 
for 60 min. After irradiation at 254 nm for 2 min membranes 
were diluted with 1 ml of 10 mM Tris-Hepes buffer (pH 
7.4)/4 mM EDTA/4 mM iodoacetamide14 mM PMSF and 
centrifuged at 48000 x g for 30 min. The resulting pellet was 
resuspended in 200 ~1 water and protein precipitated as in [20]. 
2.4. SDS gel electrophoresis 
The dried protein precipitates were dissolved in 70~1 of 
62.5 mM Tris-HCl buffer @H 6.8)/2% SDS/S% 
2-mercaptoethanol/O.OOWo br mophenol blue by shaking on a 
mixer for 60 min. After centrifugation at 15000 x g for 10 min 
the clear supernatants were submitted to SDS gel elec- 
trophoresis on 150 x 180 x 1.5 mm slab gels as described [21]. 
After fixing and staining the gels were scanned with a CD-50 
densitometer (Desaga, Heidelberg), thereafter adioactivity be- 
ing determined by liquid scintillation counting after slicing the 
gels into 2-mm pieces and after digestion of proteins with 
Biolute. 
3. RESULTS AND DISCUSSION 
The binding of [3H]glibenclamide to&cell mem- 
branes is a saturable process suggesting specific 
binding sites for glibenclamide in the &cell mem- 
brane. The specific binding of [3H]glibenclamide 
could be displaced by other sulfonylureas. It was 
demonstrated that the inhibition of [3H]gliben- 
clamide binding to &cell membranes 
Table 1 
Photocatalyzed incorporation of [3H]glibenclamide 
albumin 
by 
into 
Irradiation time (min) Incorporation of radioactivity 
(dpm) 
254 nm 300 nm 
0 <30 <30 
1 275 263 
2 745 509 
3 1089 710 
Human serum albumin (1 mg/ml) in 10 mM sodium phosphate 
buffer (pH 7.4)/140 mM NaCl was incubated with 0.25 CM 
(8 gCi/mg protein) [3H]glibenclamide at20°C for 10 min in the 
dark. Photoaffinity labeling was carried out at 254 or 300 nm. 
After 0, 1, 2 and 3 min irradiation aliquots containing 40/g 
protein were removed and protein was precipitated. The 
covalent attachment of [3H]glibenclamide to albumin was 
determined by liquid scintillation counting after SDS gel 
electrophoresis and slicing of the gels 
glibenclamide, tolbutamide and other sulfonylurea 
derivatives in vitro correlates to the blood sugar 
lowering activity in vivo [3]. Since the binding of 
[3H]glibenclamide to P-cell membranes is of high 
affinity and specific, it should be possible to iden- 
tify the respective receptor for sulfonylureas by 
photoaffinity labeling [ 16- 181. A prerequisite for 
such an approach is the availability of suitable 
photolabile derivatives of the respective ligand 
molecule. Glibenclamide contains aromatic 
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Fig.1. Distribution of radioactivity after SDS gel 
electrophoresis of @-cell membranes photolabeled with 
[3H]glibenclamide. 600 ~g/%cell membranes were incubated for 
60 min at 20°C in the dark with 48.3 nM (0.3&i) 
[‘Hlglibenclamide and subsequently irradiated at 254 nm for 
2 min. After washing of the membranes, proteins were 
separated by SDS gel electrophoresis. Total acrylamide 
concentration was 7.5%. The continuous line shows the 
distribution of Serva blue R 25~stained polypeptides, the 
dashed line denoting the distribution of radioactivity. 
Molecular masses (in kDa; at top of figure) of the marker 
proteins and the position of the tracking dye bromophenol blue 
are indicated by arrows. 
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benzene rings and aromatic O-methyl ethers within 
the molecule comprising photoreactive structures 
[16,17]. The ability of [‘Hlglibenclamide to act as 
a direct photoaffinity probe was investigated with 
human serum albumin. Albumin solutions were in- 
cubated with [3H]glibenclamide and irradiated at 
254, 300 or 350 nm. Subsequently, covalent incor- 
poration of radioactivity into the albumin 
molecule was measured by liquid scintillation 
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Fig.2. Influence of glibenclamide on photoaffinity labeling of Fig.3. Influence of tolbutamide on the photoaffinity labeling of 
&cell membranes by [‘H]glibenclamide. &Cell membranes fi-cell membranes with [3H]glibenchnnide. &Cell membranes 
(600 cg) were incubated for 60 min in the dark with 0 M (A), 
10-s M (B), IO-’ M (C), 1Om6 M (D) or lo-’ M (E) 
(600 fig) were incubated for 60 min in the dark with 0 M (A), 
lo-‘M (B), 10v6 M (C), 10e5 M (D) or lo-“ M (E) 
glibenclamide. After incubation with 60 nM (0.37 &i) tolbutamide. 
[3H]glibenclamide for 10 min in the dark the membranes were 
After incubation with 58 nM (0.36&i) 
[‘H]glibenclamide for 10 min in the dark membranes were 
photolabeled at 254 nm for 2 min. After washing of the photolabeled at 254 nm for 2 min. After washing of the 
membranes the proteins were separated by SDS gel membranes the proteins were separated by SDS gel 
electrophoresis on 7.5% gels. electrophoresis on 7.5% gels. 
counting after denaturing SDS gel electrophoresis. 
Table 1 shows that during irradiation at 254 or 
300 nm [3H]glibenclamide was covalently attached 
to albumin. Therefore, [3H]glibenclamide can be 
used for direct photoaffinity labeling of binding 
proteins for sulfonylureas in different tissues. 
Photoaffinity labeling of &cell membranes with 
[3H]glibenclamide revealed clear covalent incor- 
poration of radioactivity into two membrane 
polypeptides of apparent molecular masses of 
140 kDa (fig.1, peak a) and 33 kDa (fig.1, peak b) 
after SDS gel electrophoresis. By variation of the 
gel concentration from 6 to 15% total acrylamide 
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no additional labeled polypeptides of lower or 
higher molecular mass could be detected. Incuba- 
tion of &cell membranes with [3H]glibenclamide 
without irradiation did not result in radiolabeling 
of any membrane polypeptides, demonstrating 
photocatalyzed incorporation of radioactivity into 
the above-mentioned membrane proteins. After 
heating of the P-cell membranes to 70°C prior to 
photoaffinity labeling, no radiolabeling of mem- 
brane proteins occurred. This indicates a specific 
interaction of [3H]glibenclamide with the respec- 
tive binding proteins of the &cell membrane. Fig. 1 
shows that the distributions of radioactivity and of 
stained polypeptides are quite different 
demonstrating specific labeling of membrane pro- 
teins. The radiolabeled glibenclamide-binding 
polypeptide of 140 kDa is a minor component of 
the ,&cell membrane. 
nifedipine or ajmaline to a concentration of up to 
10m4 M exerted, in contrast to sulfonylureas, no 
significant protective effect on the labeling of 
[3H]glibenclamide-binding proteins of the &cell 
membrane (not shown). 
In conclusion, for the first time a specific 
binding protein for sulfonylureas in the cell mem- 
brane of &cells has been identified by photoaffini- 
ty labeling. We assume that this membrane 
polypeptide with an apparent molecular mass of 
140 kDa is a component of the sulfonylurea recep- 
tor in the &cell membrane. 
Acknowledgements: The authors thank F. Girbig, I. Leipe and 
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The specificity of labeling of &cell membrane 
proteins by [3H]glibenclamide was further substan- 
tiated by competition labeling experiments. 
Sulfonylureas, like unlabeled glibenclamide or 
tolbutamide, clearly decreased labeling of the 
140 kDa polypeptide in a concentration-dependent 
manner, whereas labeling of the 33 kDa polypep- 
tide was not significantly affected (figs 2,3). 
Unlabeled glibenclamide was more effective than 
tolbutamide at decreasing the extent of labeling of 
the 140 kDa polypeptide. In repeated experiments 
a half-maximal decrease in labeling was achieved 
with about 2 x 10m8 M glibenclamide, whereas 
with 2 x lo-’ M tolbutamide a lOOO-fold higher 
concentration of this sulfonylurea was necessary to 
obtain a 50% decrease in labeling of the 140 kDa 
polypeptide. This difference in sensitivity to 
photoaffinity labeling between glibenclamide and 
tolbutamide correlates clearly to their different af- 
finity in binding to the membrane and to the dif- 
ference in their hypoglycemic activity [3]. It has 
been suggested that the sulfonylurea receptor may 
be a K+ channel 19-151. The proteins of Ca2+ 
channels in various tissues have been characterized 
using different (photo)affinity probes and 
polypeptides of 140-170, 52-60 and 32-35 kDa 
have been identified as components of these Ca2’ 
channels [22-241. Since the molecular masses of 
these Ca’+-channel proteins are similar to those of 
the sulfonylurea-binding polypeptides from the P- 
cell membrane, Ca2+-channel drugs were also used 
for competition labeling experiments. Verapamil, 
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